Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 1, 1998
View Archived Issues
Anticoagulants in development at DuPont Merck
Read More
Vitamin E supplementation may prevent prostate cancer in male smokers
Read More
Case study of a patient with severe dyshidrotic eczema treated with mycophenolate mofetil
Read More
Company Profile: Direct Therapeutics
Read More
Novel antiosteoporotic compound discovered by AHP
Read More
A-74283: a 5-HT1A agonist with potent hypotensive effects in SHR
Read More
Preliminary results of TIMI 15A trial reported at ACC
Read More
New developments in signal transduction inhibition discussed at AACR meeting
Read More
Zeneca in-licenses novel chiral anesthetic agent
Read More
Pharmacokinetic study of biapenem indicates safety in various patient groups
Read More
Bayer investigates CETP inhibitors as hypolipidemic/antiatherosclerotic agents
Read More
Antibacterial quinolone carboxylic acids prepared at Bayer
Read More
NOS inhibitors claimed by Schering AG for CNS disorders
Read More
Patient enrollment in Provir phase III trial begins
Read More
Novel therapies for type II diabetes disclosed by HMR
Read More
Synthelabo claims compounds with selective affinity for certain GABA-A receptors
Read More
OPC-24439, a new sigma-receptor ligand, suppresses hippocampal neuronal activity
Read More
New vasopressin antagonist from JT with aquaretic effects in animals
Read More
Ajinomoto presents pharmacological results with novel antiarrhythmic agent
Read More
Chronic treatment with pranidipine and nicardipine compared in SHR
Read More
MCI-225: neurochemical profile of a novel antidepressant
Read More
Effects of MKC-242 on cholinergic neurons examined using in vivo microdialysis
Read More
Zenarestat potentially useful for both NIDDM- and IDDM-associated neuropathy
Read More
FDA approves DDAVP tablets for nocturnal enuresis in children
Read More
Toyama's T-593 associated with improved quality of ulcer healing compared to other H2 blockers
Read More
New diaminoguanidine for diabetes presented by Pharmacia & Upjohn
Read More
CollaGenex submits Periostat NDA amendment to FDA
Read More
Results from experimental studies suggest potential of MCC-135 in AMI, heart failure
Read More
Novel 5-HT4 agonist in development at Yoshitomi for GI motility disorders
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe